| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $217.4M | +0.3% |
| Cost of Revenue | $130.8M | +3.5% |
| R&D Expense | $154.1M | -12.0% |
| SG&A Expense | $77.7M | -4.0% |
| Operating Income | -$154.2M | +9.3% |
| Interest Expense | $17.6M | +90.6% |
| Pre-tax Income | -$153.7M | -5.2% |
| Income Tax | -$3.0M | -56.8% |
| Net Income | -$143.1M |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $145.5M | -47.0% |
| Accounts Receivable | $57.5M | +10.5% |
| Inventory | $48.6M | -2.5% |
| Current Assets | $285.8M | -30.1% |
| Total Assets | $840.8M | -10.7% |
| Current Liabilities | $76.5M | -9.8% |
| Long-term Debt | $353.4M | -7.3% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$57.1M | +2.5% |
| Capital Expenditures | $14.3M | -0.3% |
| Investing Cash Flow | -$32.0M | -66.0% |
| Financing Cash Flow | -$38.9M | -118.6% |
| Free Cash Flow | -$71.4M | +2.1% |
| -7.9% |
| EPS (Basic) | -$0.73 | +3.9% |
| EPS (Diluted) | -$0.73 | +3.9% |
| Total Liabilities |
| $456.8M |
| -7.9% |
| Stockholders' Equity | $358.0M | -14.3% |